OCUL
Ocular Therapeutix, Inc.
NASDAQ · USHealthcareBiotechnology
$8.71-2.90%
Price as of Jul 20, 2026
OCUL capital
Ocular Therapeutix, Inc. capital & dividend
Leverage, liquidity, debt coverage and shareholder-distribution metrics.
Leverage
- Debt / equity
- 0.14x
- Net debt / equity
- -1.01x
- Debt / assets
- 0.11x
- Debt / EBITDA
- -0.29x
- Net debt / EBITDA
- 2.14x
Liquidity & coverage
- Current ratio
- 14.81x
- Quick ratio
- 14.73x
- Cash ratio
- 13.98x
- Interest coverage
- -25.75x
- EBITDA / interest
- -23.59x
- Working capital
- $658.3M
Cash & dividend
- FCF / debt
- -3.03x
- Cash flow / debt
- -2.85x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.